How has Denali Therapeutics Inc.'s accrued manufacturing costs changed year-over-year?

Denali Therapeutics Inc.'s accrued manufacturing costs increased by 20.4% year-over-year, from $7.66M to $9.22M.

What is the long-term trend for Denali Therapeutics Inc.'s accrued manufacturing costs?

Over 5 years (2020 to 2025), Denali Therapeutics Inc.'s accrued manufacturing costs has grown at a 9.4% compound annual growth rate (CAGR), from $20.5M to $32.18M.

Denali Therapeutics Inc. DNLI Accrued Manufacturing Costs

Accrued Manufacturing Costs at other companies

Eli LillyLLY

——

BridgeBio PharmaBBIO

——

BioMarin PharmaceuticalsBMRN

——

Neurocrine BiosciencesNBIX

——

Other financials

Income statement

See full

Revenue-—

Operating income-$137.4M+5.6%

Net income-$128.4M+3.4%

EPS (diluted)-$0.69+11.5%

Balance sheet

See full

Cash & equivalents$390.7M+551%

Total debt$40.0M-22.3%

Total equity$926.1M-17.5%

Total assets$1.3B-0.4%

Cash flow

See full

Operating cash flow-$131.2M+0.2%

CapEx$2.5M-51.4%

Free cash flow-$133.7M+2.1%

Valuation

See full

Market cap$3.93B+54.2%

Profitability

See full

Operating margin-37,938%-37,986pp

Net margin-33,121.9%-33,159pp

FCF margin-31,736.3%-31,830pp

Returns & leverage

See full

Return on equity-49.6%+34.2pp

Debt / equity0×0.0×

Current ratio9.3×-0.3×

Where this comes from

Reported directly by Denali Therapeutics Inc. in its filing.

Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.

The official record: Denali Therapeutics Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Denali Therapeutics Inc.'s accrued manufacturing costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Denali Therapeutics Inc.'s accrued manufacturing costs?: Denali Therapeutics Inc. (DNLI) reported accrued manufacturing costs of $9.22M in Q1 2026.
How has Denali Therapeutics Inc.'s accrued manufacturing costs changed year-over-year?: Denali Therapeutics Inc.'s accrued manufacturing costs increased by 20.4% year-over-year, from $7.66M to $9.22M.
What is the long-term trend for Denali Therapeutics Inc.'s accrued manufacturing costs?: Over 5 years (2020 to 2025), Denali Therapeutics Inc.'s accrued manufacturing costs has grown at a 9.4% compound annual growth rate (CAGR), from $20.5M to $32.18M.